Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · iShares

iShares Global Healthcare ETF (IXJ)

Ticker IXJ · Since 2001-11-13 · · Holdings as of Jun 30, 2026

Expense ratio
0.38%$38/yr per $10k
5-yr return
+6.4%annualized
1-yr return
+14.9%as of Dec 2025
Net assets
$3.8Ball share classes
Holdings
124

Bottom line

Is IXJ a good fund? The bottom line

IXJ is an actively managed health care sector ETF from iShares.

Its expense ratio is 0.38% — about $38 a year on every $10,000 invested, cheaper than 87% of health care sector funds we track.

It returned +14.9% over one year, +6.4% a year over five years, +8.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $3.8 billion in net assets and 124 holdings, its largest position is Eli Lilly And Company (10.9%) and the top 10 make up 47.8% of the portfolio.

The closest lower-cost alternative we found is XLV (0.08%, 76% top-holdings overlap).

What stands out

  • Low cost: cheaper than 87% of health care sector peers
  • 5-year return beat 75% of category peers

Updated Nov 19, 2026

What IXJ invests in

The iShares Global Healthcare ETF (the Fund ) seeks to track the investment results of an index composed of global equities in the healthcare sector.

The Fund seeks to track the investment results of the S&P Global 1200 Health Care (Sector) Capped Index TM (the Underlying Index ), which measures the performance of companies that S&P Dow Jones Indices LLC (the Index Provider or SPDJI ), a subsidiary of S&P Global, Inc., deems to be a part of the healthcare sector of the economy and that SPDJI believes are important to global markets. The Underlying Index is a subset of the S&P Global 1200, which is designed to measure the performance of large-capitalization stocks from major global markets, as determined by SPDJI. As of March 31, 2026, a significant portion of the Underlying Index was represented by securities of companies in the healthcare industry or sector. The components of the Underlying Index are likely to change over time. As of March 31, 2026, the Underlying Index was composed of securities of companies in the following…

From the fund's prospectus (filed Jul 27, 2026).

IXJ performance

Fund calendar-year total returns, 2015–2025 2015: +5.9%; 2016: −6.2%; 2017: +20.3%; 2018: +2.9%; 2019: +23.4%; 2020: +12.5%; 2021: +19.5%; 2022: −4.7%; 2023: +3.5%; 2024: +0.6%; 2025: +14.9% +6% 2015 −6% 2016 +20% 2017 +3% 2018 +23% 2019 +12% 2020 +19% 2021 −5% 2022 +3% 2023 +1% 2024 +15% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
IXJ+14.9%+6.4%+8.2%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full IXJ performance history →

What IXJ costs

On a $10,000 investment, IXJ's 0.38% expense ratio costs about $38 a year. The prospectus estimates $480 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full IXJ fee table →

IXJ top 10 holdings

#Holding% of fund
1Eli Lilly And Company10.93%
2Johnson & Johnson7.04%
3Abbvie Inc.5.12%
4Unitedhealth Group Incorporated4.40%
5Merck & Co., Inc.4.12%
6Astrazeneca Plc3.76%
7Roche Holding AG3.75%
8Novartis AG3.71%
9Amgen Inc.2.54%
10Thermo Fisher Scientific Incorporated2.42%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 47.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to IXJ

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SPDR (State Street)XLV State Street(R) Health Care Select…0.08%76% Compare
FidelityFHLC Fidelity MSCI Health Care Index ETF0.084%76% Compare
VanguardVHT Vanguard Health Care Index Fund0.09%78% Compare
J.P. MorganJDOC JPMorgan Healthcare Leaders ETF0.65%68% Compare
SchwabSWHFX Schwab Health Care Fund0.8%76% Compare
T. Rowe PricePRHSX T. Rowe Price Health Sciences Fund, Inc.0.83%70% Compare

More funds like IXJ →

IXJ FAQ

What is the expense ratio of IXJ?
IXJ's expense ratio is 0.38%, which works out to about $38 a year for every $10,000 invested. The prospectus estimates total costs of $480 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is IXJ a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 87% of health care sector peers; 5-year return beat 75% of category peers. This is general information, not personalized advice.
What does IXJ hold?
IXJ's largest holdings are Eli Lilly And Company (10.9%), Johnson & Johnson (7.0%), Abbvie Inc. (5.1%), Unitedhealth Group Incorporated (4.4%), Merck & Co., Inc. (4.1%). It holds 124 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is IXJ's 5-year return?
IXJ returned +6.4% a year over the five years ending Dec 31, 2025, and +8.2% a year over ten years. Past performance does not guarantee future results.
What is a cheaper alternative to IXJ?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) overlaps about 76% with IXJ and charges 0.08%.
Who manages IXJ?
IXJ is offered by iShares through iSHARES TRUST.